Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Feb;19(2):264–266. doi: 10.1128/jcm.19.2.264-266.1984

Escherichia coli K5 antigen in relation to various infections and in healthy individuals.

B Kaijser, U Jodal
PMCID: PMC271034  PMID: 6199369

Abstract

A phage specific for Escherichia coli K5 antigen was used to determine the frequency of K5 in strains of E. coli isolated from cases of sepsis, meningitis, and urinary tract infection (pyelonephritis, cystitis, and asymptomatic bacteriuria), as well as from fecal samples of healthy subjects. Although entirely absent from meningitic strains, K5 was found to be one of the most common E. coli capsular antigens, especially in strains causing sepsis. K5 was less common in the fecal strains of healthy subjects than in strains causing various urinary tract infections, between which there was no significant difference in its frequency. Thus, even if K5 is a less important antigen than K1 in the etiology of acute pyelonephritis or acute meningitis, as the fifth most commonly occurring K antigen in E. coli strains causing urinary tract infection it should be included as a component in any K antigen-based vaccine against acute pyelonephritis.

Full text

PDF
264

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jann K., Jann B. The K antigens of Escherichia coli. Prog Allergy. 1983;33:53–79. doi: 10.1159/000407421. [DOI] [PubMed] [Google Scholar]
  2. Jodal U., Lindberg U., Lincoln K. Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand. 1975 Mar;64(2):201–208. doi: 10.1111/j.1651-2227.1975.tb03822.x. [DOI] [PubMed] [Google Scholar]
  3. Kaijser B., Hanson L. A., Jodal U., Lidin-Janson G., Robbins J. B. Frequency of E. coli K antigens in urinary-tract infections in children. Lancet. 1977 Mar 26;1(8013):663–666. doi: 10.1016/s0140-6736(77)92111-0. [DOI] [PubMed] [Google Scholar]
  4. Kaijser B. Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection. J Infect Dis. 1973 Jun;127(6):670–677. doi: 10.1093/infdis/127.6.670. [DOI] [PubMed] [Google Scholar]
  5. Kaijser B., Larsson P., Nimmich W., Söderström T. Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis. Prog Allergy. 1983;33:275–288. doi: 10.1159/000318336. [DOI] [PubMed] [Google Scholar]
  6. Kaijser B., Larsson P., Olling S., Schneerson R. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin. Infect Immun. 1983 Jan;39(1):142–146. doi: 10.1128/iai.39.1.142-146.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaijser B., Svanborg-Edén C., Wadström T. High frequency of K15 antigen in enterotoxigenic Escherichia coli: lack of correlation to adherence to epithelial cells or sensitivity to bactericidal effect of normal serum. Zentralbl Bakteriol Orig A. 1978 Nov;242(1):17–22. [PubMed] [Google Scholar]
  8. Kaijser B., Vahlne G. Escherichia coli K antigen. Zentralbl Bakteriol Orig A. 1979 Apr;243(2-3):271–288. [PubMed] [Google Scholar]
  9. Lidin-Janson G., Falsen E., Jodal U., Kaijser B., Lincoln K. Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children. J Med Microbiol. 1977 Aug;10(3):299–308. doi: 10.1099/00222615-10-3-299. [DOI] [PubMed] [Google Scholar]
  10. Lidin-Janson G., Hanson L. A., Kaijser B., Lincoln K., Lindberg U., Olling S., Wedel H. Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis. 1977 Sep;136(3):346–353. doi: 10.1093/infdis/136.3.346. [DOI] [PubMed] [Google Scholar]
  11. McCabe W. R., Kaijser B., Olling S., Uwaydah M., Hanson L. A. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis. 1978 Jul;138(1):33–41. doi: 10.1093/infdis/138.1.33. [DOI] [PubMed] [Google Scholar]
  12. Orskov I., Orskov F., Jann B., Jann K. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev. 1977 Sep;41(3):667–710. doi: 10.1128/br.41.3.667-710.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Robbins J. B. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry. 1978 Nov;15(10-11):839–854. doi: 10.1016/0161-5890(78)90117-7. [DOI] [PubMed] [Google Scholar]
  14. Vann W. F., Schmidt M. A., Jann B., Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur J Biochem. 1981 May 15;116(2):359–364. doi: 10.1111/j.1432-1033.1981.tb05343.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES